I'll focus purely upon GAL and LEG as we sit between them along...

I'll focus purely upon GAL and LEG as we sit between them along strike and in the case of GAL, our initial assays are in fact, marginally better than theirs. When you look at the enterprise values, the market is currently saying that CR1 has a 17% chance of emulating GAL and a 2% chance of emulating LEG. For CR1 to emulate the current enterprise values of GAL and LEG, the share price would roughly be, $1.91 (5.8 times higher) and $15.60 (47.4 times higher) respectively. If the options price were to trail the heads by their 20 cent strike price, they'd be $1.71 or 12.2 times higher for GAL and $15.40 or 110 times higher for LEG. The risk reward is quite obscene when considering it's cash on hand places CR1 in the empty shell category.